Fostamatinib for the Treatment of Adult Persistent and Chronic ITP...
- 09 May 2018 |
ITP in the News
Allegheny County settles with parents improperly accused of child abuse
- 07 February 2018 |
Former ‘Tenors’ Singer Remigio Pereira Reveals Health Scare, Shares Update With Fans
- 08 October 2017 |
Red Deer’s Canadian Blood Services saves lives
- 26 September 2017 |
Cayden, ITP patient, recognized at Green Bay Packers' game
- 22 September 2017 |
Splenectomy vs. rituximab as a second-line therapy in immune thrombocytopenic purpura: a single center experience
- 22 September 2017 |
argenx reaches 50% enrollment in Phase 2 clinical trial of ARGX-113 in immune thrombocytopenia
- 22 September 2017 |
Novartis’ Revolade proved effective for seniors
- 11 September 2017 |
Protalex Doses First Patient in Third Cohort of European Phase 1b Study of PRTX-100 in ITP
- 05 September 2017 |
Role of Polymorphisms in Idiopathic Thrombocytopenic Purpura: A Review
- 05 September 2017 |
Quick Consult: Symptom: Arm and Back Rash
- 05 September 2017 |
Mum’s heartbreak at having to ban her five-year-old daughter from playing with her friends
- 21 August 2017 |
Protalex Completes Data Analysis of Second Dose Cohort of U.S. Phase 1/2 Study of PRTX-100 in ITP
- 02 August 2017 |
Oklahoma researchers zero in on cause of blood disorder
- 31 July 2017 |
FDA Accepts New Drug Application for Chronic ITP Treatment
- 22 June 2017 |
Weill Cornell team creates breakthrough on blood disorders
- 10 June 2017 |
Bishop Sutton student's warrior spirit
- 16 May 2017 |
